Dark Blue Therapeutics is a startup based in the United Kingdom, most recent round Acquired, 2 tracked investors.
Based in the United Kingdom, Dark Blue Therapeutics is a startup. Dark Blue Therapeutics has been acquired. Brouky records 2 investors associated with the company.
Dark Blue Therapeutics is a biotechnology company specializing in precision oncology, leveraging academic partnerships to develop targeted therapies for cancer by exploiting novel vulnerabilities and dependencies in cancer cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.